Advocacy News

SITC Hosts Rare and Challenging Cases: Increasing Access to IO Webinar

By SITC Advocacy posted 2 days ago
This webinar on September 26th examined how rare and challenging cases, such as extremes of age, immunocompromised, ...
0 comments
 
Cancer Research Policy Modality Webinar

SITC Hosts Predicting Drug Resistance and Drug Repurposing with Imaging-Based AI: AI in Immuno-oncology Webinar

By SITC Advocacy posted 9 days ago
Increased understanding of immunotherapy mechanisms of action may enhance researchers’ ability to circumvent ...
0 comments
 
Cancer Research Policy Modality Webinar User-Generated   AIinIO

SITC Comments on FDA Guidance

By SITC Advocacy posted 15 days ago
SITC has provided comment on the recently posted "Diversity Action Plans to Improve Enrollment of Participants ...
0 comments
 
Cancer Research Policy User-Generated   FDA

SITC Hosts Predicting Early Diagnosis and Response with Multimodal AI: AI in Immuno-Oncology Webinar

By SITC Advocacy posted 25 days ago
Earlier cancer diagnosis, as well as rapid determination of tumor response after treatment, could lead ...
0 comments
 
Cancer Research Policy Modality Webinar User-Generated   AIinIO

SITC Hosts Immune Checkpoint Inhibitors: Increasing Access to IO Webinar

By SITC Advocacy posted 08-21-2024
This webinar on August 15th examined how immune checkpoint inhibitors are being utilized around the globe ...
0 comments
 
Cancer Research Policy Modality Webinar

SITC Hosts Social Determinants of Health with Large/Moderate Language Models on EHR Data: AI in Immuno-oncology Webinar

By SITC Advocacy posted 08-06-2024
Social determinants of health are becoming increasingly understood as having significant impact in immunotherapy ...
0 comments
 
Cancer Research Policy Modality Webinar User-Generated   AIinIO

Crisis in Clinical Research, a Commentary

By SITC Advocacy posted 07-22-2024
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the publication of a commentary ...
0 comments
 
Cancer Research Policy User-Generated   Crisis   JITC

SITC Hosts Cell Therapy Administration: Increasing Access to IO Webinar

By SITC Advocacy posted 07-17-2024
This webinar on July 10th examined how cell therapies are being utilized around the globe and in resource ...
0 comments
 
Cancer Research Policy Modality Webinar

Call for Comment - Surrogate Endpoints Virtual Summit Executive Summary

By SITC Advocacy posted 07-12-2024
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the publication of a comprehensive ...
0 comments
 
Cancer Research Policy

SITC Hosts Opportunities and Implications for IO Using AI and Digital Pathology: AI in Immuno-Oncology Webinar

By SITC Advocacy posted 06-27-2024
Digital pathology is becoming an increasingly important technique for immunotherapy drug development ...
0 comments
 
Cancer Research Policy Modality Webinar User-Generated   AIinIO

SITC Hosts The Current Landscape of IO Access: Increasing Access to IO Webinar

By SITC Advocacy posted 06-12-2024
This webinar on June 5th reviewed effective strategies for cancer immunotherapy administration by providing ...
0 comments
 
Cancer Research Policy Modality Webinar User-Generated   Global

SITC Hosts AI in Personalized Immunotherapies: AI in Immuno-Oncology Webinar

By SITC Advocacy posted 05-22-2024
The vision of personalized medicine based on tumor-specific biomarkers comes closer to reality with each ...
0 comments
 
Cancer Research Policy Modality Webinar User-Generated   AIinIO

SITC Hosts Real-Time AI Monitoring & Early Detection of Immune-Related Adverse Events: AI in Immuno-Oncology Webinar

By SITC Advocacy posted 05-09-2024
AI is being investigated for real-time monitoring of patients receiving immunotherapy for immune-related ...
0 comments
 
Cancer Research Policy Modality Webinar User-Generated   AIinIO

SITC In-Person on the Hill 2024 - Thank You Dr. Sullivan

By SITC Advocacy posted 05-01-2024
SITC thanks Policy Committee chair Dr. Ryan Sullivan and many other SITC members for assisting with this ...
0 comments
 
Cancer Research Policy User-Generated   SITContheHill

Announcing Increasing Access to IO: A Global Webinar Series

By SITC Advocacy posted 04-24-2024
The Global Access and Impact Committee, in collaboration with the Diversity, Equity, and Inclusion Committee, ...
0 comments
 
Cancer Research Policy Modality Webinar

SITC and Association of Cancer Care Center collaborate on new webinar

By SITC Advocacy posted 04-03-2024
SITC and ACCC have collaborated on a new webinar aimed at providing further details on the Expanding ...
0 comments
 
Cancer Research Policy Modality Webinar

SITC provides comment on Draft FDA Guidance

By SITC Advocacy posted 03-27-2024
SITC has provided full comments on a recently released FDA Draft Guidance: "Potency Assurance for Cellular ...
0 comments
 
Cancer Research Policy

SITC provides meeting coverage on March 15th ODAC meeting

By SITC Advocacy posted 03-20-2024
SITC has provided meeting coverage of the March 15th ODAC meeting. The coverage includes an overview ...
0 comments
 
Cancer Research Policy

SITC provides letter to Oncologic Drug Advisory Committee (ODAC)

By SITC Advocacy posted 03-12-2024
SITC has provided a letter to ODAC providing insight into the implications of control arm crossover use ...
0 comments
 
Cancer Research Policy

SITC on the Hill 2024 - Thank you Dr. Tarhini

By SITC Advocacy posted 03-05-2024
Thank you to Dr. Ahmad Tarhini from Moffitt Cancer Center and Research Institute for partici ...
0 comments
 
Cancer Research Policy User-Generated   SITContheHill